Browsing by Subject "Checkpoint inhibitor"
Now showing items 1-1 of 1
-
Failed immune responses across multiple pathologies share pan-tumor and circulating lymphocytic targets
( American Society for Clinical Investigation , 2019 , Article)Tumor-infiltrating lymphocytes (TILs) are widely associated with positive outcomes, yet carry key indicators of a systemic failed immune response against unresolved cancer. Cancer immunotherapies can reverse their tolerance ...